Expression of T-type Ca 2+ current in the ventricle varies during development and in cardiac diseases. The alteration in quantity of two isoforms of T-type Ca 2+ channel genes in the heart, CACNA1G and CACNA1H, contributes to the changes of T-type Ca 2+ channel activity. However, the precise mechanisms governing the transcription of T-type Ca 2+ channel genes remain largely unknown. In this review, we briefly describe our recent finding that a transcriptional repressor named neuron-restrictive silencer factor is a potent regulator of T-type Ca 2+ channel gene expression.
Introduction
Electrophysiological analysis using ventricular myocytes from different species reveals that T-type Ca 2+ current is not expressed in normal adult ventricular myocytes of many species other than guinea pigs and sharks (1, 2) . T-type Ca 2+ current in adult heart is restricted to the conduction system. In contrast, T-type Ca 2+ current is recorded in ventricular myocyte from embryonic and neonatal hearts (3) . In addition, the analyses of T-type Ca 2+ current in several models of cardiac hypertrophy or myocardial infarction suggest the increased or de novo functional expression of T-type channel in the ventricle (4) . The alterations in gene expression level of two alpha1 subunits of T-type Ca 2+ channel expressed in the heart, α 1G (CACNA1G) and α 1H (CACNA1H), contribute to the changes of T-type Ca 2+ current in development and pathological conditions. However little is known about the molecular mechanisms regulating T-type Ca 2+ channel genes expression. In this review, we briefly describe our recent finding that a transcriptional repressor named neuron-restrictive silencer factor (NRSF) regulates T-type Ca 2+ channel expression in the ventricle.
NRSE regulates CACNA1H gene expression
Accumulating evidence indicate that cardiac hypertrophy is accompanied by the reactivation of a fetal cardiac gene program including an increase in the gene expression of atrial and brain natriuretic peptides (ANP and BNP, respectively). Expression of such fetal cardiac genes in the ventricle normally decreases during the postnatal period and remain quiescent in the adult ventricular myocardium. In efforts to find the mechanisms regulating the gene transcription of ANP and BNP, we identified a repressor element neuron-restrictive silencer element (NRSE) that controls the expression of both ANP and BNP in cardiac ventricular myocytes (5, 6) . NRSE, also known as repressor element-1 (RE-1), was originally defined as a negative-acting DNA regulatory element that prevents expression of neuronal genes in non-neuronal cell types and undifferentiated neuronal cells. NRSE present in the regulatory region of many neuronal genes is important for their neuronspecific expression. A transcriptional repressor NRSF also known as RE-1 silencing transcription factor (REST), is known as a NRSE-binding protein. NRSF is expressed widely in most non-neuronal cells including adult heart and suppresses neuron-specific genes expression (7 -9) . NRSF is also expressed in undifferentiated neuronal progenitor cells in the nervous system, and *Corresponding author. FAX: +81-75-771-9452 E-mail: koichiro.kuwahara@UTSouthwestern.edu down regulation of NRSF expression leads to the expression of neuron-specific terminal genes during neuronal development. Recently, not only neuronspecific genes but also genes expressed in non-neuronal cells have been reported to contain NRSE. The evidence indicates that NRSF functions as a transcriptional regulator for NRSE-containing genes in non-neuronal tissues. We have shown that the NRSE-NRSF system normally represses the transcription of ANP and BNP genes in the ventricular myocytes and that under pathological conditions, the de-repression of NRSF-mediated repression of ANP and BNP is involved in the reactivation of ANP and BNP gene expression (5, 6) . Furthermore we identified NRSE in the 3'untranslated region (UTR) of skeletal α-actin gene, another fetal cardiac gene. These results suggest that NRSF participates in the transcriptional regulation of multiple fetal cardiac genes. To find the potent target genes of NRSF in the heart, we searched the genomic database using NRSE sequences and found that the CACNA1H gene contains NRSE-like sequences in its 1st intron. NRSE-like sequences in CACNA1H have 93% identity with NRSE consensus sequences and are well conserved among different mammalian species (Fig. 1A) . We confirmed the binding of NRSF to the sequences (10). In addition, when we created transgenic mice carrying cardiac-specific expression of a dominant-negative mutant of NRSF, CACNA1H gene expression was significantly increased in the ventricle of the transgenic mice (DNNRSF Tg).
In contrast, we could not find NRSE in the CACNA1G gene and CACNA1G was not increased in the TG ventricle. These results clearly demonstrate that the NRSE-NRSF system regulates the expression of CACNA1H as well as ANP and BNP. This is consistent with the notion that T-type Ca 2+ current is expressed in the fetal hearts, but not in the normal adult ventricle. CACNA1H gene expression is decreased during human development (11) . It should be noted that little expression of NRSF and its corepressor mSIN3A and HDAC1 is detected in embryonic hearts, although they are expressed in the adult hearts (12 -14) . The increased expression of NRSF repressor complex may contribute to the repression of T-type Ca 2+ current during the ventricular maturation. Indeed, T-type Ca 2+ current is activated in DNNRSF Tg ventricular myocytes, whereas it is not detectable in adult non-Tg ventricular myocytes (10) . Treatment of nonselective T-type Ca 2+ channel blocker, mibefradil, shows beneficial results in many animal models of heart failure, suggesting the implication of aberrant T-type channel expression in the progression of cardiac malfunction (15) . Interestingly DNNRSF Tg mice show dilated cardiomyopathy, ventricular arrhythmias, and sudden death. The increased T-type Ca 2+ current may be involved in the progression of cardiac dysfunction and ventricular arrhythmias in DNNRSF Tg mice. As we have described above, de-repression of NRSF-mediated repression contributes to the reactivation of ANP and BNP gene transcription in pathological conditions. Considering that T-type Ca 2+ current is also activated in cardiac hypertrophy, the increased expression of CACNA1H gene by de-repression of NRSF-mediated repression may be involved in the reactivation of T-type Ca 2+ current in hypertrophied ventricle and contribute to the progression of cardiac dysfunction (Fig. 2) .
Conclusion
We identified a novel transcriptional regulatory mechanism of T-type Ca 2+ channel gene in the heart. It is not determined yet whether the increase in T-type Ca 2+ currents is responsible for the development of dilated cardiomyopathy and increased arrhythmogenesis in DNNRSF Tg mice. We are currently administering Ttype Ca 2+ channel blocker to DNNRSF Tg mice. It is not also unclear whether the increase in CACNA1H gene expression is responsible for the activation T-type Ca 2+ Fig. 1 . NRSE in CACNA1H gene of different mammalian species. current in cardiac hypertrophy and whether the derepression of NRSF-mediated repression contributes to that increase in vivo. Further studies are necessary to find answers to these questions.
